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Objective. To compare birth weight ratio and birth weight percentile to express infant weight when assessing pregnancy outcome.
Study Design. We performed a national cohort study. Birth weight ratio was calculated as the observed birth weight divided by
the median birth weight for gestational age. The discriminative ability of birth weight ratio and birth weight percentile to identify
infants at risk of perinatal death (fetal death and neonatal death) or adverse pregnancy outcome (perinatal death + severe neonatal
morbidity) was compared using the area under the curve. Outcomes were expressed stratified by gestational age at delivery separate
for birth weight ratio and birth weight percentile. Results. We studied 1,299,244 pregnant women, with an overall perinatal death
rate of 0.62%. Birth weight ratio and birth weight percentile have equivalent overall discriminative performance for perinatal death
and adverse perinatal outcome. In late preterm infants (33+0–36+6 weeks), birth weight ratio has better discriminative ability than
birth weight percentile for perinatal death (0.68 versus 0.63, 𝑃 0.01) or adverse pregnancy outcome (0.67 versus 0.60, 𝑃 < 0.001).
Conclusion. Birthweight ratio is a potentially valuable instrument to identify infants at risk of perinatal death and adverse pregnancy
outcome and provides several advantages for use in research and clinical practice. Moreover, it allows comparison of groups with
different average birth weights.
1. Introduction
Gestational age at delivery and birth weight are considered
important predictors of adverse pregnancy outcome [1, 2].
Accurate assessment of fetal growth in relation to gestational
age is therefore an important tool for risk assessment in
antenatal care.
Fetal growth is usually expressed in percentiles. Birth
weight percentile curves are calculated from cross-sectional
data of newborns [3]. Thus, birth weight percentiles (BWper-
centiles) indicate the value (e.g., 10%) below which a certain
percentage of the observations in a group of newborns (10%)
can be found. BWpercentiles are often dichotomized, and
small for gestational age (SGA) is commonly defined as birth
weight below the 10th, 5th, or 2.3th percentile for gestational
age in a population-specific reference growth curve [4, 5].
The BWpercentile tells us if an infant belongs to a certain
part of the percentile distribution but does not contain any
information about the absolute deviation of infant weight
from the median birth weight for gestation. As a result,
percentiles do not allow comparison of growth between
groups with different growth characteristics (e.g., different
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sexes or ethnicities). Moreover, at the tails of the normal
distribution (e.g., at the 2nd percentile), a percentile contains
amuchwider range of absolute birth weights than close to the
median (e.g., at the 50th percentile). Consequently, the use
of percentiles and their dichotomization may lead to loss of
information that may be useful for patient care and parental
counseling.
Birth weight ratio (BWratio) is an alternative method to
express growth of an individual with respect to the median.
It is defined as the ratio of observed birth weight divided by
the median birth weight of the population-specific reference
growth curve. Values above 1 indicate “larger for gestational
age than the median” and values below 1 indicate “smaller for
gestational age than themedian.” It may offer a solution to the
limitations associated with BWpercentiles.
Our objective was to compare BWratio and BWpercentile
to express infant growth when assessing pregnancy outcome.
2. Materials and Methods
2.1. Dataset. This study was performed using a nationwide
cohort using data from The Netherlands Perinatal Registry
(PRN). The PRN consists of population-based data on preg-
nancies, deliveries, neonatal characteristics, and readmis-
sions until 28 days after birth. The PRN database is obtained
by a validated linkage of three different registries, the mid-
wifery registry, the obstetrics registry, and the neonatology
registry of hospital admissions of newborn neonates [6, 7].
Records are entered in the PRN registry at the child’s level.
The coverage of the PRN registry is approximately 96% of
all deliveries in The Netherlands. It contains pregnancies of
≥22 weeks’ gestation and a birth weight of ≥500 g and is used
primarily for an annual assessment of the quality indicators
of obstetric care.
2.2. Ethical Approval. The data in the perinatal registry are
anonymous; therefore ethical approval was not needed. The
Dutch Perinatal Registry gave their approval to use their data
for this study (approval number 13.72).
2.3. Inclusion and Exclusion Criteria. We included all white
women who delivered a singleton between 25+0 and 42+6
weeks gestation in The Netherlands between January 1, 1999,
and December 31, 2007. All cases with congenital anomalies
were excluded [8].
2.4. Outcome Measures. Outcome measures were perinatal
death and a composite of perinatal death and neonatal mor-
bidity. Perinatal death was defined as the sum of intrauterine
fetal death (diagnosed after 25+0 weeks GA) and neonatal
death (until 28 days after birth). The composite of adverse
pregnancy outcome consisted of perinatal death, respiratory
distress syndrome (RDS), sepsis, necrotizing enterocolitis
(NEC), meconium aspiration, and intraventricular hemor-
rhage (IVH) within the first month of birth. If an infant
suffered from neonatal morbidity and died within 28 days
after birth, it was only considered as perinatal death in the
analyses.
TheDutch reference curves for birthweight by gestational
age stratified for parity, sex, and ethnic backgroundwere used
[9]. Pregnancy dating was performed using last menstrual
period (LMP) or by ultrasound measurements before 20
weeks of gestation (crown-rump-length (CRL) or head-
circumference (HC) measurement).
We defined SGA as birth weight below the 10th or
5th percentile for gestation. To obtain the best possible
comparability with SGA, low BWratio cut-off values of 0.85
and 0.80 were chosen such that (after rounding them to the
closest 0.05 value) they resulted in equally large groups of low
BWratio infants in the whole population as with the 10th and
5th birth weight percentiles.
We defined LGA as birth weight above the 90th or
95th percentile for gestation. To obtain the best possible
comparability with LGA, high BWratio cut-off values 1.25 and
1.30 were chosen such that (after rounding them to the closest
0.05 value) they resulted in groups of high BWratio infants in
the whole population that corresponds best with the 90th and
95th birth weight percentiles.
2.5. Population Characteristic and Clinical Characteristics.
We registered demographic and obstetric characteristics
including maternal age, parity, and socioeconomic status
(SES) [10]. Parity was categorized into 0 (first birth), 1 (second
birth), and 2+ (third or higher birth).
2.6. Statistics. Baseline characteristics were described and
presented as means with standard deviations (SD), median
with range, or percentages as appropriate.
We tested for interaction between BWratio and GA
at delivery as well as BWpercentile and GA at delivery.
These tests were performed separately for the two outcome
measures. If statistically significant (𝑃 < 0.05), analyses
were performed stratified for gestational age at delivery in
four categories according to the WHO criteria, extremely
preterm (24+0–27+6 weeks’ gestation), very preterm (28+0–
32+6 weeks’ gestation), moderate to late preterm (33+0–
36+6 weeks’ gestation), and term delivery (37+0–42+6 weeks’
gestation) [11].
We plotted distributions of perinatal death and adverse
pregnancy outcome for BWratio and BWpercentile. In addi-
tion distributions of perinatal death and adverse pregnancy
outcome stratified for gestational age at delivery for BWratio
and BWpercentile were plotted.
We also calculated—separate for BWratio and BWper-
centile and four strata of gestational age at birth—the
population-attributable risk (PAR) of abnormal fetal growth
for perinatal death and adverse pregnancy outcome. PARwas
based on the prevalence (𝑃) of abnormal growth and the
relative risk (RR) of perinatal death and adverse pregnancy
outcome in abnormally grown (low BWratio, SGA) and
normally grown infants: PAR% = [𝑃 ∗ (RR − 1)/(𝑃 ∗ (RR −
1) + 1)] ∗ 100 [12].
Finally, receiver operator characteristics (ROC) curves
were constructed for the whole cohort and for abnormally
grown infants only, to compare discriminative ability of birth
weight ratio and birth weight percentile for our outcome
Obstetrics and Gynecology International 3





Maternal age, mean, (SD) 30.7 (4.58)
Nulliparous, % 47.5
Low socioeconomic status, % 18.9
Boys 51.3
Pregnancy and delivery
Induction of labor, % 35.3
Cesarean section 14.3
Elective cesarean section % 6.2
Emergency cesarean section % 11.3
Vaginal instrumental delivery 12.4
Neonatal characteristics
Gestational age at delivery (weeks), median (IQR) 39,2 (1.86)
Extremely premature (GA < 29+0 weeks), 𝑛 (%) 4,048 (0.3)
Very premature (GA < 33+0 weeks), 𝑛 (%) 13,885 (1.1)
Mild premature (GA < 37+0 weeks), 𝑛 (%) 75,429 (5.81)
SD, standard deviation.
measures (perinatal death and adverse pregnancy outcome)
in the four gestational categories. All statistical tests were 2-
sided; a probability value of 0.05 was chosen as the threshold
for statistical significance.
The data were analyzed with the SAS statistical software
package (version 9.2; SAS Institute Inc., Cary, NC).
3. Results
From January 1, 1999 until December 31, 2007 a total of
1,636,565 pregnancies were registered in the PRN database.
We excluded cases that were nonwhite (𝑛 = 258,908
(15.82%)), multiple pregnancies (𝑛 = 63,857 (3.90%)), infants
with congenital anomalies (𝑛 = 22,043 (1.35%)), and infants
born before 25+0 weeks or after 42+6 weeks GA (𝑛 = 6,967
(0.43%)). After application of the inclusion and exclusion
criteria the study population consisted of 1,299,244 pregnan-
cies. Baseline characteristics of the population are shown in
Table 1.
3.1. Distribution of Cases. The distribution of birth weight
ratios and birth weight percentiles for four strata of gesta-
tional age at birth is shown in Figures 1(a) and 1(b). Figure 1(a)
shows that most infants are born with a BWratio around one
and that both higher and lower BWratios are less common.
Moreover, 80% of cases had a BWratio between 0.85 and
1.25. These infants occupy approximately one-third of the
width of the graph, while the low BWratio and high BWratio
infants occupy the remaining two-thirds. Hence, the spread
in BWratio is much larger in the extremes of the birth weight
ratio distribution than when using birth weight percentiles.
These characteristics of BWratio distributions make it pos-
sible to better distinguish between different degrees of low
BWratios and high BWratios.
Figure 1(b) contains the distribution of birth weight
percentiles and shows that the population is cut into 100
(approximately) equal parts. As a result, any given percentile
always contains about 1% of the population. Consequently,
the central 80% of the graph represents 80% of the popula-
tion, while this only corresponds to approximately one-third
of the BWratio distribution. Whereas SGA and LGA infants
(20% of the population) logically cover 20% of the percentile
distribution, while this group represents the remaining two-
thirds of the BWratio distribution.
Figure 1(a) also shows that the BWratio of late premature
(33+0–36+6 weeks’ gestation) and term (37+0–42+6 weeks)
infants is normally distributed. Distribution of the birth
weight ratio of extremely premature (25+0–28+6 weeks’ gesta-
tion) or very premature infants (29+0–32+6 weeks gestation)
is negatively skewed.
3.2. Incidence of Abnormal Growth. The lines in Figure 1(a)
suggest higher rates of low BWratios and high BWratios
among infants that are born preterm. At term (37–42 weeks
GA), 9.67% [118,331/1,223,815] of infants are born with a
BWratio < 0.85. In the preterm period the incidences are sig-
nificantly higher (𝑃 < 0.001) than in the term group, 17.04%
[10,487/61,544] (33–36 weeks), 25.73% [2,531/9,837] (29–32
weeks), and 37.8% [1,530/4,084] (25–28 weeks), respectively.
At term (37–42 weeks GA), 6.64% [81,312/1,223,815] of
infants are born with a high BWratio (>1.25). In the preterm
period, the incidences are significantly higher (𝑃 < 0.001)
than in the term group, 8.43% [5,188/61,544] (33–36 weeks),
18.39% [1,809/9,837] (29–32 weeks) and 16.48% [667/4,084]
(25–28 weeks), respectively.
These findings confirm the presence of an association
between prematurity and the incidence of abnormal growth
(BWratio < 0.85 as well as BWratio > 1.25) [13–15].
3.3. Perinatal Death and Composite Morbidity. Incidences of
perinatal death and adverse pregnancy outcome are shown in
Figures 2 and 3. Incidences are shown separate for four strata
of gestational age at birth, by birth weight ratios (Figures
2(a) and 3(a)), and birth weight percentiles (Figures 2(b) and
3(b)).
Comparison of mortality rates in Figures 2(a) and 2(b)
shows that especially in the late preterm period (33–36
weeks) and at term (37–42 weeks) birth weight ratio allows
more accurate differentiation between different SGA grades
than birth weight percentiles. This is illustrated by Figure 2.
Although it seems in Figure 2(b) that perinatal death between
33 and 36 weeks gestation does not rise above 10% in infants
with a birthweight at the 1st percentile, Figure 2(a) shows that
perinatal death rate rises until over 40%, depending on the
severity of growth restriction.
On the other side of the growth spectrum, birth weight
ratio also allows more precise differentiation between differ-
ent severities of LGA.
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Figure 1: The incidence of birth weight ratios and birth weight percentiles for four strata of gestational age at birth separate for birth weight
ratio (a) and birth weight percentiles (b).






















































Figure 2: Incidences of perinatal death stratified by gestational age at delivery separate for birth weight ratio (a) and birth weight percentiles
(b).
Both birth weight ratio and birth weight percentile show
a gestation related death rate in the normal range (BWratio
0.85–1.25 and p10–p90, resp.) with higher death rates towards
both ends of the growth spectrum. The same effects at
the ends of the growth spectrum were found for adverse
pregnancy outcome (Figures 3(a) and 3(b)).
3.4. Population-Attributive Risk of Abnormal Growth for
Death and Adverse Pregnancy Outcome. The percentage of
perinatal death and adverse pregnancy outcome that can be
attributed to abnormal growth depends on gestational age at
delivery, on whether abnormal growth is defined by BWratio
(low/high BWratio) or BWpercentile (SGA/LGA), and on
the cut-off value that is used. PAR of abnormal fetal growth
for perinatal death at different gestational ages is shown in
Table 2. Depending on gestation and on the definition of
abnormal growth, 14–35% of perinatal death and 2–13% of
adverse pregnancy outcome can be attributed to abnormal
growth.
The population-attributive risk of abnormal growth is
higher for death than for adverse pregnancy outcome, which
means that a larger percentage of perinatal deaths than
adverse pregnancy outcome can be attributed to abnormal
growth. PAR of suboptimal growth for perinatal death is
small in extremely premature infants, increases with advanc-
ing gestational age with a peak in late preterm infants (33–36
weeks), and decrease at term.























































Figure 3: Incidences of adverse perinatal outcome stratified by gestational age at delivery separate for birth weight ratio (a) and birth weight
percentiles (b).
Table 2: Population-attributive risk of abnormal fetal growth, for four definitions of abnormal growth by birth weight ratio and birth weight
percentile.
Population-attributive risk percentage (PAR%)
Birth weight ratio Birth weight percentile
<0.80 <0.85 <p5 <p10
25–28 weeks
Perinatal death 26 28 18 23
Composite adverse outcome 3 3 2 2
29–32 weeks
Perinatal death 24 27 14 20
Composite adverse outcome 5 6 3 4
33–36 weeks
Perinatal death 29 35 19 25
Composite adverse outcome 11 12 10 13
37–42 weeks
Perinatal death 18 24 17 22
Composite adverse outcome 9 11 7 8
Also, PAR of abnormal growth, for example, for perinatal
death at term, is higher if less stringent cut-off values to define
abnormal growth are chosen (e.g., the 10th percentile instead
of the 5th percentile, 22% versus 17%).
3.5. Discriminative Ability of Birth Weight Ratio and Birth
Weight Percentile. The areas under the receiver operator
characteristics curves are shown in Table 3. When assessing
the complete growth spectrum, there were no differences
in areas under the curve (AUC) between birth weight ratio
and birth weight percentile to distinguish between those
with and without perinatal death in extremely preterm, very
preterm, late preterm, and term infants. Accordingly, the
discriminative ability of birth weight ratio and birth weight
percentile for our composite adverse pregnancy outcome
did not differ at any gestational age either. The discrimi-
native ability of both methods for death was poor to fair
(range 0.64–0.73), and the discriminative ability for adverse
pregnancy outcome was bad to poor (range 0.55–0.65)
[16].
When we assessed SGA cases only (birth weight below
the 10th percentile), the discriminative ability of BWratio was
better than that of BWpercentile for death in the late preterm
period (33+0–36+6 weeks) (0.68 versus 0.63, 𝑃 0.01) and at
term (0.69 versus 0.67, 𝑃 0.05) (Table 4). The discriminative
ability of BWratio was also better than that of BWpercentile
for adverse pregnancy outcome in the late preterm period
(33+0–36+6 weeks) (0.67 versus 0.60, 𝑃 < 0.001).
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Table 3: Discriminative ability to predict perinatal death or adverse outcome of birth weight ratio and birth weight percentile.
Area under the curve
𝑃 value
Birth weight ratio Birth weight percentile
25–28 weeks
Perinatal death 0.73 0.73 0.78
Composite adverse outcome 0.65 0.65 1.00
29–32 weeks
Perinatal death 0.65 0.65 0.88
Composite adverse outcome 0.56 0.56 0.82
33–36 weeks
Perinatal death 0.70 0.69 0.69
Composite adverse outcome 0.56 0.56 1.00
37–42 weeks
Perinatal death 0.64 0.64 0.77
Composite adverse outcome 0.55 0.55 0.22
Table 4: Discriminative ability of birth weight ratio and birth weight percentile in case of birth weight below the 10th percentile for gestational
age.
Area under the curve
𝑃 value
Birth weight ratio Birth weight percentile
25–28 weeks
Perinatal death 0.70 0.76 0.09
Composite adverse outcome 0.61 0.63 0.75
29–32 weeks
Perinatal death 0.69 0.68 0.67
Composite adverse outcome 0.61 0.58 0.43
33–36 weeks
Perinatal death 0.68 0.63 0.01
Composite adverse outcome 0.67 0.60 <0.001
37–42 weeks
Perinatal death 0.69 0.67 0.05
Composite adverse outcome 0.65 0.64 0.15
4. Discussion
Discriminative ability of BWratio for perinatal death or
adverse pregnancy outcome is comparable to that of birth
weight percentile. Birth weight ratio is—for smaller and
larger than average infants—a more discriminative instru-
ment for perinatal death and adverse pregnancy outcome
than birth weight percentile.
Our findings confirm an association between abnormal
fetal growth and premature delivery [13–15], and our data
show that approximately one out of five perinatal deaths can
be attributed to being SGA.
4.1. Limitations. Some limitations need to be addressed. First,
a possible limitation is related to the use population-based
birth weight percentiles. Although there exists no unanimity
about the question whether references should be based
on population birth weight characteristics or on individual
growth potential, the latter might have better discriminative
ability for adverse outcome [13, 17–23], both with BWratios
and BWpercentiles. We were not able to use customized
growth curves because of maternal length and weight, and
placental weight and pathology are not registered in the
Dutch Perinatal Registry. Therefore the Dutch reference
curves for birth weight by gestational age separate for parity,
sex, and ethnic background were used [9]. We think however
that not being able to use customized growth curves was
only a minor limitation, because the concepts put forward in
this paper can also be applied if growth is expressed using
customized charts.
A second potential limitation is the use of preterm birth
weight as standards for preterm BWratio.This might have led
to an underestimation of the effect of prematurity on preg-
nancy outcome because—as this study shows—prematurity
is associated with abnormal growth.
Finally, the PRN database does not contain data on
how pregnancy dating is performed. Until 2011, no uniform
pregnancy dating was performed in The Netherlands. His-
torically, it was common practice to date pregnancies based
on LMP. Since the 1980’s the use of ultrasound was gradu-
ally introduced in obstetric care. During our study period
crown rump length and head circumference measurements
Obstetrics and Gynecology International 7
had already increasingly replaced LMP for dating, but no
quantitative data are available on how pregnancy was dated
in individual cases. Inaccurate pregnancy dating might be
partially responsible for the wider birth weight spread in the
preterm period. However, this wider spread in the preterm
period might also be the result of higher incidences of
pathologically small or large growth, leading to preterm
delivery.
4.2. Strengths. The main strength of this study is the size
(1,299,244 pregnancies) and composition (only white women
with a singleton without congenital anomalies) of the cohort.
The incidence of fetal deaths, neonatal deaths, perinatal
deaths, and composite morbidity that we found in this study
is in accordance with previous research [24–29]. There is no
reason to suspect a systematical gender or parity based bias.
The concepts discussed in this paper can be used to assess
distribution of growth and risk of abnormal growth and its
relation to pregnancy outcome in other populations.
Data are derived from a large, well-maintained
population-based national perinatal registry (1999–2007).
The vast majority of the caregivers contribute to the PRN
registry; therefore, it comprises approximately 96% of all
pregnancy and birth characteristics in The Netherlands. The
4% missing birth data are due to 1-2% nonreporting general
practitioners and 2-3% nonreporting midwives. The use of
population-based growth curves for white mothers, separate
for gender and parity, minimizes risk of systematic bias
caused by one of these factors.
Finally, this is to our knowledge the first study that
compared birth weight ratio and birth weight percentiles
using ROC curves.This allowed us to statistically substantiate
our findings.
4.3. Interpretation of the Results. As shown in Figure 1(b),
only a distribution based on BWratio tells us how growth is
distributedwithin a population. It shows thatmost infants are
born with a birth weight ratio of around one, and incidences
of BWratios decrease towards both ends of the distribution.
This study confirms that preterm delivery is associated
with increased SGA and LGA rates as compared to term
delivery [14, 15] and that the relation between fetal growth
and the risk of adverse pregnancy outcome also depends on
gestational age at delivery. This means that the relative risk
of adverse outcome for an infant with a certain BWratio or
BWpercentile at 30 weeks gestation is not the same as that at
40 weeks’ gestation.
The results also show that birth weight ratios are not
normally distributed in infants that are delivered extremely—
or very preterm (25+0–32+6 weeks) (Figure 1(a)). Percentiles
are only suitable for use in a normally distributed population
and are therefore less suitable to express growth in premature
and extremely premature infants.
Finally, birth weight ratio allows comparison of groups
with different average weights and weight distributions, for
example, male infants and female infants or infants of dif-
ferent ethnic origins. Percentiles and ratios both allow com-
parison of groups, but—as explained before—information on
distance from the mean and the incidence of different ratios
within a population is lost when percentiles are used.
The different representation of growth with BWratio
and BWpercentile that is explained above has two effects
that result in better interpretability of infant growth when
BWratio is used.
First, the use of BWpercentile causes a loss of discrimi-
native power, especially among SGA and LGA infants. For
example, all infants with birthweight <1st percentile (1% of
the population and BWpercentile distribution) cover about
10% of the BWratio distribution, thus allowing better differ-
entiation within this group of small infants with BWratio.
Second, birth weight percentiles suggest that an infant
(born at term) with a birth weight at the 25th percentile is
much lighter than an infant at the 75th percentile. However,
this is not the case. The birth weight ratios in this example
are 0.9 (25th percentile) and 1.1 (75th percentile) and are both
very close to 1.0. The seemingly large difference if growth is
expressed in percentiles is caused by the fact that a population
is by definition divided into 100 equally large groups instead
of groups based on birth weight in relation to the median and
that most infants have a birth weight close to the median.
There are two reasons for the fact that neither BWper-
centile nor BWratio has high sensitivity and specificity for
death and adverse outcome and that only a limited proportion
of death and adverse outcome can be attributed to fetal
growth below the 10th percentile.
First, unlike other tests, increased risk of death (or adverse
outcome) is not associated with a one-directional change in
the risk factor (birth weight ratio or percentile). Both low and
high birth weight ratios (or percentiles) are associated with
increased risk of death (or adverse outcome).
Second, both death and adverse outcome occur at all
gestational ages and across thewhole growth spectrum.There
seems to be a gestational age related basic risk (horizontal part
of the line) with increased death and adverse outcome rates
at both ends of the growth spectrum.
5. Conclusions
In view of the results we think that BWratio could comple-
ment BWpercentiles in clinical practice and can play a role
in scientific research. It allows differentiation of SGA infants
that is not possible with BWpercentile; it is easy to understand
and therefore useful for patient counseling. This study pro-
vides in our opinion sufficient evidence for clinicians to use
birth weight ratios when assessing risks of adverse outcome
when an infant is suspected to be extremely small or large for
gestation. Finally, birth weight ratio enables comparison of
populations with different baseline characteristics.
This study shows the need to redefine cut-off values
that define abnormal fetal growth. Historically, these cut-off
values have been set at the 2.5th, 5th, and 10th percentile.
However, this study shows that the relation between fetal
growth and the risk of adverse pregnancy outcome differs
depending on gestational age at delivery. Therefore, future
research should focus on defining cut-off values to identify
infants at risk of clinically relevant poor growth. To do this,
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consequences of abnormal growth should be weighed against
potential treatment benefit of early detection and interven-
tion, also taking into account costs of follow-up and potential
adverse effects of interventions. Given the potentially better
associations with adverse pregnancy outcome, such research
should be performed using customized weight percentiles.
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